Caitlin Raymond/LinkedIn
Mar 27, 2026, 17:09
Caitlin Raymond: Jehovah’s Witnesses May Now Accept Autologous Blood
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared on LinkedIn:
”On March 20th, the Governing Body of Jehovah’s Witnesses issued new guidance: members may now accept autologous blood.
Preoperative autologous deposit – long explicitly forbidden – has moved into the personal conscience category.
This is significant. But if you work in transfusion medicine, the headlines don’t quite tell the whole story.
A few things worth knowing:
- The conscience zone was already wide before this update. Cell salvage, hemodilution, cardiopulmonary bypass, dialysis – individual decisions for years. The zone just got wider.
- Actual clinical practice has always been variable. I’ve cared for Jehovah’s Witness patients who would accept platelets (despite the contamination with allogeneic RBCs), and some who would even accept directed donations from congregation members. Jehovah’s Witness patients are whole, complex people, not policy documents.
- Autonomy without access isn’t really autonomy. PAD requires infrastructure that doesn’t exist uniformly across the 200+ countries where Jehovah’s Witnesses live and receive surgical care.
- ‘It’s now allowed’ doesn’t mean patients will feel free to accept it. Conscience operates inside a community. The conversation at the bedside still requires care, privacy, and time.
The guidance changed. The complexity didn’t.”

Stay updated with Hemostasis Today.
-
Mar 27, 2026, 17:06Tareq Abadl: The Importance of CBC Analysis in Detecting Lupus Activity
-
Mar 27, 2026, 17:03Louise St. Germain Bannon: Making Adherence Easier, More Human and More Achievable for Everyone on World Adherence Day
-
Mar 27, 2026, 16:58Promising Thrombin Biomarkers For Identifying High-Risk VTE Patients – JTH
-
Mar 27, 2026, 16:53Brecca Gaffney: The Role of Hemophilia Severity on Movement Patterns
-
Mar 27, 2026, 16:46Anita Brikman: Expanding Access to Plasma-Derived Medicines in India
-
Mar 27, 2026, 16:26Robert Talac: Platelet Concentration Gap – PRP vs Advanced PRF
-
Mar 27, 2026, 16:23Nathan Wong: Lp(a) Testing as a Class I Recommendation in 2026 Guidelines
-
Mar 27, 2026, 16:21Jeff Sternlicht: Inflammation is The ‘Storm’ Before Atherosclerosis
-
Mar 27, 2026, 16:19Laura Baglow-Micic: Register for the Transfusion Research Network for The SWiFT Trial Results Webinar